Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya
Background: Currently, no data are available on the prevalence of red blood cell (RBC) antibody formation amongst Kenyan patients with multiple transfusion needs, such as patients with sickle cell disease (SCD) or haematological malignancies (HM) and solid (SM) malignancies. Objectives: We determin...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2015-09-01
|
| Series: | African Journal of Laboratory Medicine |
| Online Access: | https://ajlmonline.org/index.php/ajlm/article/view/297 |
| _version_ | 1818248771270606848 |
|---|---|
| author | Caroline Mangare Amos Mbugua Peter Maturi Jamila Rajab Rainer Blasczyk Hans-Gert Heuft |
| author_facet | Caroline Mangare Amos Mbugua Peter Maturi Jamila Rajab Rainer Blasczyk Hans-Gert Heuft |
| author_sort | Caroline Mangare |
| collection | DOAJ |
| description | Background: Currently, no data are available on the prevalence of red blood cell (RBC) antibody formation amongst Kenyan patients with multiple transfusion needs, such as patients with sickle cell disease (SCD) or haematological malignancies (HM) and solid (SM) malignancies.
Objectives: We determined the prevalence and specificities of RBC alloantibodies and autoantibodies in two patient groups with recurrent transfusion demands at Kenyatta National Hospital, Nairobi, Kenya.
Method: Between February and August 2014, 300 samples from SCD, HM and SM patients were collected and screened for alloantibodies. Samples from 51 healthy blood donors were screened for irregular antibodies and phenotyped.
Results: Amongst the 228 patients with viable samples (SCD, n = 137; HM, n = 48; SM, n = 43), the median transfusion frequency was two to three events per group, 38 (16.7%) were RBC immunised and 32 (14.0%) had a positive direct antiglobulin test. We identified specific alloantibodies in six patients (2.6%). Four of these six were SCD patients (2.9%) who had specific RBC alloantibodies (anti-Cw, anti-M, anti-Cob, anti-S); amongst HM patients one had anti-K and one had anti-Lea. RBC autoantibody prevalence was 3.1% (7/228). Amongst the healthy blood donors, the Ror, ccD.ee and R2r, ccD.Ee phenotypes accounted for 82% of the Rhesus phenotypes and all were Kell negative.
Conclusion: The numbers of transfusions and the rates of RBC alloantibodies are low and the most important RBC alloantibody-inducing blood group antigens are relatively homogeneously distributed in this population. A general change in the Kenyatta National Hospital pre-transfusion test regimen is thus not necessary. The current transfusion practice should be reconsidered if transfusion frequencies increase in the future. |
| first_indexed | 2024-12-12T15:25:53Z |
| format | Article |
| id | doaj.art-93cfe846898c46d1b26f89da17c139e8 |
| institution | Directory Open Access Journal |
| issn | 2225-2002 2225-2010 |
| language | English |
| last_indexed | 2024-12-12T15:25:53Z |
| publishDate | 2015-09-01 |
| publisher | AOSIS |
| record_format | Article |
| series | African Journal of Laboratory Medicine |
| spelling | doaj.art-93cfe846898c46d1b26f89da17c139e82022-12-22T00:20:16ZengAOSISAfrican Journal of Laboratory Medicine2225-20022225-20102015-09-0141e1e710.4102/ajlm.v4i1.29793Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, KenyaCaroline Mangare0Amos Mbugua1Peter Maturi2Jamila Rajab3Rainer Blasczyk4Hans-Gert Heuft5Jomo Kenyatta University of Agriculture and Technology, NairobiJomo Kenyatta University of Agriculture and Technology, NairobiKenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, NairobiKenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, NairobiInstitute for Transfusion Medicine, Hannover Medical School, HannoverInstitute for Transfusion Medicine, Hannover Medical School, HannoverBackground: Currently, no data are available on the prevalence of red blood cell (RBC) antibody formation amongst Kenyan patients with multiple transfusion needs, such as patients with sickle cell disease (SCD) or haematological malignancies (HM) and solid (SM) malignancies. Objectives: We determined the prevalence and specificities of RBC alloantibodies and autoantibodies in two patient groups with recurrent transfusion demands at Kenyatta National Hospital, Nairobi, Kenya. Method: Between February and August 2014, 300 samples from SCD, HM and SM patients were collected and screened for alloantibodies. Samples from 51 healthy blood donors were screened for irregular antibodies and phenotyped. Results: Amongst the 228 patients with viable samples (SCD, n = 137; HM, n = 48; SM, n = 43), the median transfusion frequency was two to three events per group, 38 (16.7%) were RBC immunised and 32 (14.0%) had a positive direct antiglobulin test. We identified specific alloantibodies in six patients (2.6%). Four of these six were SCD patients (2.9%) who had specific RBC alloantibodies (anti-Cw, anti-M, anti-Cob, anti-S); amongst HM patients one had anti-K and one had anti-Lea. RBC autoantibody prevalence was 3.1% (7/228). Amongst the healthy blood donors, the Ror, ccD.ee and R2r, ccD.Ee phenotypes accounted for 82% of the Rhesus phenotypes and all were Kell negative. Conclusion: The numbers of transfusions and the rates of RBC alloantibodies are low and the most important RBC alloantibody-inducing blood group antigens are relatively homogeneously distributed in this population. A general change in the Kenyatta National Hospital pre-transfusion test regimen is thus not necessary. The current transfusion practice should be reconsidered if transfusion frequencies increase in the future.https://ajlmonline.org/index.php/ajlm/article/view/297 |
| spellingShingle | Caroline Mangare Amos Mbugua Peter Maturi Jamila Rajab Rainer Blasczyk Hans-Gert Heuft Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya African Journal of Laboratory Medicine |
| title | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| title_full | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| title_fullStr | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| title_full_unstemmed | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| title_short | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| title_sort | red cell allo and autoimmunisation in transfused sickle cell and cancer patients in kenyatta national hospital nairobi kenya |
| url | https://ajlmonline.org/index.php/ajlm/article/view/297 |
| work_keys_str_mv | AT carolinemangare redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya AT amosmbugua redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya AT petermaturi redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya AT jamilarajab redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya AT rainerblasczyk redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya AT hansgertheuft redcellalloandautoimmunisationintransfusedsicklecellandcancerpatientsinkenyattanationalhospitalnairobikenya |